Drug Shortage Report for YAZ PLUS
Report ID | 215319 |
Drug Identification Number | 02387433 |
Brand name | YAZ PLUS |
Common or Proper name | Drospirenone/ estradiol/ Levomefolate Calcium |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | LEVOMEFOLATE CALCIUM LEVOMEFOLATE CALCIUM ETHINYL ESTRADIOL DROSPIRENONE |
Strength(s) | 0.451MG 0.451MG 0.02MG 3.00MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 28's |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-01-19 |
Actual start date | |
Estimated end date | 2024-01-26 |
Actual end date | 2024-01-18 |
Shortage status | Avoided shortage |
Updated date | 2024-01-18 |
Company comments | Production Issues. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-01-18 | French | Compare |
v3 | 2024-01-18 | English | Compare |
v2 | 2024-01-08 | French | Compare |
v1 | 2024-01-08 | English | Compare |
Showing 1 to 4 of 4